Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

Mylotarg

gemtuzumab
  • Restricted
  • Restricted Mylotarg --> inpatient use restricted to newly diagnosed CD33 positive AML patients receiving combination therapy induction or consolidation treatment.
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Mylotarg POWDER FOR INJECTION, INTRAVENOUS 5 mg      
Comments:

Mylotarg restricted to oncology. Inpatient use restricted to newly diagnosed CD33 positive AML patients receiving combination therapy induction or consolidation treatment. 

Reviewed: 24 April 2018, and 24 July 2018.

Last updated: Jun. 28, 2022






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved